Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

A rare skin condition usually found near the eyes was found on a farmer's scalp.

Brevilin-A is a safe and effective treatment for mild to moderate alopecia areata in children.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

ERULUS is crucial for root hair growth by controlling calcium levels.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

The treatment cleared psoriasis in some patients but caused side effects in most.

A new mutation in the KRT86 gene causes a hair disorder with variable expression.

A new type of nerve cell involved in itch perception was discovered.

Genital rejuvenation is becoming popular for improving genital appearance and function in both men and women.

KRDQN effectively predicts adverse drug reactions with high accuracy and clear explanations.

KX-826 is safe and effectively increases hair count in men with hair loss.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

The Exfoliate-Dissolve-Repair skincare approach may effectively treat keratosis pilaris and reduce the need for corticosteroids.

Ruxolitinib treatment may cause eyelash growth.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Revertant cell therapy shows promise for treating type XVII collagen deficiency, but better cell selection methods are needed.

An 8-year-old boy with Recklinghausen's Disease shows various symptoms and is from a family with close genetic ties.